Combined Use of 18F-FDG PET/CT and MRI To Monitor Breast Cancer Response during Neoadjuvant Chemotherapy.
Pengel, K. E., Koolen, B. B., Vogel, W., Valdes, Olmos R., Wesseling, J., Vrancken, Peeters M-J, Loo, C. E., Gilhuijs, K. G.
DOI: https://doi.org/10.1158/0008-5472.SABCS11-P3-14-06
Cancer Research 71